RecruitingNCT03998059

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment

50 participants

Start Date

Jan 23, 2019

Study Type

OBSERVATIONAL

Conditions

Thrombocytopenia Splenectomy

Summary

Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.

Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called splenectomy for people with splenectomy and thrombocytopenia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREsplenectomy

These patients should fail to have sustained response to multiple first- and second-line treatments of ITP and agree to have splenectomy.Before splenectomy, these patients will be reassessed and still diagnosed with ITP.Their platelet level will be raised to a safe state before surgery, and the laparoscopic splenectomy will be performed in Tianjin People's Hospital.